Correlation Between Cue Biopharma and Mind Medicine

Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Mind Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Mind Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cue Biopharma and Mind Medicine, you can compare the effects of market volatilities on Cue Biopharma and Mind Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Mind Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Mind Medicine.

Diversification Opportunities for Cue Biopharma and Mind Medicine

0.54

Correlation Coefficient

Cue Biopharma  Mind Medicine

Very weak diversification

The 3 months correlation between Cue and Mind is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Mind Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mind Medicine and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Mind Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mind Medicine has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Mind Medicine go up and down completely randomly.

Pair Corralation between Cue Biopharma and Mind Medicine

Considering the 90-day investment horizon Cue Biopharma is expected to generate 1.21 times more return on investment than Mind Medicine. However, Cue Biopharma is 1.21 times more volatile than Mind Medicine. It trades about 0.01 of its potential returns per unit of risk. Mind Medicine is currently generating about -0.01 per unit of risk. If you would invest  108.00  in Cue Biopharma on December 26, 2024 and sell it today you would lose (8.00) from holding Cue Biopharma or give up 7.41% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.36%
Values	Daily Returns

Cue Biopharma  vs.  Mind Medicine

Cue Biopharma

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cue Biopharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Cue Biopharma is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Mind Medicine

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mind Medicine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Mind Medicine is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Cue Biopharma and Mind Medicine

The main advantage of trading using opposite Cue Biopharma and Mind Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Mind Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mind Medicine will offset losses from the drop in Mind Medicine's long position.

The idea behind Cue Biopharma and Mind Medicine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.